LHC Group, Inc. (NASDAQ:LHCG) shares traded down 6.1% on Friday . The stock traded as low as $84.15 and last traded at $85.98. 576,620 shares were traded during trading, an increase of 104% from the average session volume of 283,036 shares. The stock had previously closed at $91.61.

Several research analysts have recently weighed in on the stock. Zacks Investment Research lowered shares of LHC Group from a “buy” rating to a “sell” rating in a report on Wednesday, July 4th. BidaskClub lowered shares of LHC Group from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 10th. Craig Hallum lowered shares of LHC Group from a “buy” rating to a “hold” rating and cut their price objective for the stock from $99.00 to $92.00 in a report on Friday. Jefferies Financial Group increased their price objective on shares of LHC Group to $120.00 and gave the stock a “buy” rating in a report on Friday, August 3rd. Finally, Royal Bank of Canada increased their price objective on shares of LHC Group to $101.00 and gave the stock a “sector perform” rating in a report on Friday, August 3rd. Four analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. LHC Group currently has a consensus rating of “Buy” and a consensus target price of $103.00.

The stock has a market capitalization of $2.69 billion, a PE ratio of 31.49, a P/E/G ratio of 1.35 and a beta of 0.52. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.59 and a current ratio of 1.59.

LHC Group (NASDAQ:LHCG) last posted its earnings results on Wednesday, August 1st. The health services provider reported $0.84 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.78 by $0.06. The firm had revenue of $502.00 million during the quarter, compared to the consensus estimate of $509.03 million. LHC Group had a net margin of 3.75% and a return on equity of 8.33%. The company’s revenue was up 95.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.63 EPS. As a group, research analysts anticipate that LHC Group, Inc. will post 3.52 earnings per share for the current year.

In related news, SVP Jeff Reibel sold 1,921 shares of the stock in a transaction that occurred on Monday, August 20th. The shares were sold at an average price of $94.12, for a total transaction of $180,804.52. Following the completion of the sale, the senior vice president now owns 8,125 shares of the company’s stock, valued at approximately $764,725. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Donald Dwayne Stelly sold 2,756 shares of the stock in a transaction that occurred on Friday, September 7th. The stock was sold at an average price of $99.32, for a total transaction of $273,725.92. Following the sale, the chief operating officer now directly owns 104,512 shares of the company’s stock, valued at approximately $10,380,131.84. The disclosure for this sale can be found here. 6.80% of the stock is currently owned by corporate insiders.

Large investors have recently modified their holdings of the business. Voya Investment Management LLC grew its position in LHC Group by 65.9% in the second quarter. Voya Investment Management LLC now owns 11,818 shares of the health services provider’s stock valued at $1,012,000 after acquiring an additional 4,694 shares in the last quarter. Alps Advisors Inc. acquired a new stake in LHC Group in the second quarter valued at approximately $442,000. FMR LLC grew its position in LHC Group by 297.8% in the second quarter. FMR LLC now owns 1,151,406 shares of the health services provider’s stock valued at $98,548,000 after acquiring an additional 861,952 shares in the last quarter. Waddell & Reed Financial Inc. grew its position in LHC Group by 4.6% in the second quarter. Waddell & Reed Financial Inc. now owns 526,400 shares of the health services provider’s stock valued at $45,055,000 after acquiring an additional 23,200 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. grew its position in LHC Group by 71.5% in the second quarter. Schwab Charles Investment Management Inc. now owns 193,202 shares of the health services provider’s stock valued at $16,537,000 after acquiring an additional 80,518 shares in the last quarter. 86.00% of the stock is owned by institutional investors.

LHC Group Company Profile (NASDAQ:LHCG)

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Read More: What is the balance sheet?

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.